Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 7/20 | 0.40 |
| ▸ | CES1 | P23141 | 6/20 | 0.40 |
| ▸ | CES2 | O00748 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Heptane SCHEMBL7077193 | 0.90 | TSHR (0.47) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Hexane SCHEMBL28293459 | 0.87 | FAAH (0.44) | HSD17B10MEN1KMT2ATSHRSMN1; SMN2 | |
| Dodecanol SCHEMBL21384923 | 0.79 | LMNA (0.77) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Tridecan-1-Ol SCHEMBL27691275 | 0.79 | LMNA (0.77) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Cetyl Alcohol SCHEMBL27711529 | 0.79 | LMNA (0.77) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL25421234 | 0.79 | LMNA (1.00) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Cetostearyl Alcohol SCHEMBL20515901 | 0.79 | LMNA (1.00) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Decane SCHEMBL11319155 | 0.79 | LMNA (1.00) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Myristyl Alcohol SCHEMBL21352636 | 0.79 | LMNA (1.00) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Docosanol SCHEMBL21218972 | 0.79 | LMNA (1.00) | LMNAALDH1A1HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6613358-B2 | Contacting an organic solvent with co-dissolved a biocompatible polymer and a hydrophobic ion pair complex of an amphiphilic material and pharmaceutical with a compressed antisolvent fluid | ENDO PHARMACEUTICALS, INC. | 2003-09-02 | — | — | US | disclosed |
| US-20020132007-A1 | Sustainded-release composition including amorphous polymer | UNIVERSITY TECHNOLOGY CORPORATION | 2002-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020132007-A1 | Sustainded-release composition including amorphous polymer | CHERP, ATP2A1, ATP2A3 | LMNA 1490/4885ALDH1A1 4501/4885HSD17B10 2121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.